Literature DB >> 27804262

Effects of end-stage renal disease and dialysis modalities on blood ammonia level.

Nosratola D Vaziri1, Mahyar Khazaeli1, Ane C F Nunes1, Kevin T Harley1, Hyder Said1, Omeed Alipour1, Wei Ling Lau1, Madeleine V Pahl1.   

Abstract

INTRODUCTION: Uremia results in a characteristic breath odor (uremic fetor) which is largely due to its high ammonia content. Earlier studies have shown a strong correlation between breath ammonia and blood urea levels and a 10-fold reduction in breath ammonia after hemodialysis in patients with chronic kidney disease. Potential sources of breath ammonia include: (i) local ammonia production from hydrolysis of urea in the oropharyngeal and respiratory tracts by bacterial flora, and (ii) release of circulating blood ammonia by the lungs. While the effects of uremia and hemodialysis on breath ammonia are well known their effects on blood ammonia are unknown and were explored here.
METHODS: Blood samples were obtained from 23 hemodialysis patients (immediately before and after dialysis), 14 peritoneal dialysis patients, and 10 healthy controls. Blood levels of ammonia, creatinine, urea, and electrolytes were measured.
FINDINGS: No significant difference was found in baseline blood ammonia between hemodialysis, peritoneal dialysis and control groups. Hemodialysis procedure led to a significant reduction in urea concentration (P < 0.001) which was paradoxically accompanied by a modest but significant (P < 0.05) rise in blood ammonia level in 10 of the 23 patients studied. Change in blood ammonia pre- and post-hemodialysis correlated with change in serum bicarbonate levels (r = 0.61, P < 0.01). On subgroup analysis of patients who had a rise in blood ammonia levels after dialysis, there was a strong correlation with drop in mean arterial pressure (r = 0.88, P < 0.01). The nadir intradialytic systolic blood pressure trended lower in the hemodialysis patients who had a rise in blood ammonia compared to the patients who manifested a fall in blood ammonia (124 ± 8 vs. 136 ± 6 mmHg respectively, P = 0.27). DISCUSSION: Fall in blood urea following hemodialysis in ESRD patients was paradoxically accompanied by a modest rise in blood ammonia levels in 43% of the patients studied, contrasting prior reported effects of hemodialysis on breath ammonia. In this subgroup of patients, changes in blood ammonia during hemodialysis correlated with rise in blood bicarbonate and fall in mean arterial blood pressure.
© 2016 International Society for Hemodialysis.

Entities:  

Keywords:  Uremia; chronic kidney disease; dialysis; inflammation; urea

Mesh:

Substances:

Year:  2016        PMID: 27804262      PMCID: PMC5812671          DOI: 10.1111/hdi.12510

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  26 in total

1.  Urea concentration in intestinal fluids in normal and uremic dogs.

Authors:  Y T Lee
Journal:  J Surg Oncol       Date:  1971       Impact factor: 3.454

2.  Chronic kidney disease alters intestinal microbial flora.

Authors:  Nosratola D Vaziri; Jakk Wong; Madeleine Pahl; Yvette M Piceno; Jun Yuan; Todd Z DeSantis; Zhenmin Ni; Tien-Hung Nguyen; Gary L Andersen
Journal:  Kidney Int       Date:  2012-09-19       Impact factor: 10.612

3.  Breath ammonia and trimethylamine allow real-time monitoring of haemodialysis efficacy.

Authors:  Z H Endre; J W Pickering; M K Storer; W-P Hu; K T Moorhead; R Allardyce; D O McGregor; J M Scotter
Journal:  Physiol Meas       Date:  2010-12-08       Impact factor: 2.833

Review 4.  Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.

Authors:  Nosratola D Vaziri; Ying-Yong Zhao; Madeleine V Pahl
Journal:  Nephrol Dial Transplant       Date:  2015-04-16       Impact factor: 5.992

5.  Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Authors:  Nosratola D Vaziri; Jun Yuan; Keith Norris
Journal:  Am J Nephrol       Date:  2012-12-19       Impact factor: 3.754

Review 6.  Intestinal nitrogen recycling and utilization in health and disease.

Authors:  Werner G Bergen; Guoyao Wu
Journal:  J Nutr       Date:  2009-03-12       Impact factor: 4.798

7.  Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption.

Authors:  Nosratola D Vaziri; Jun Yuan; Mahyar Khazaeli; Yuichi Masuda; Hirohito Ichii; Shuman Liu
Journal:  Am J Nephrol       Date:  2013-05-15       Impact factor: 3.754

Review 8.  Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease.

Authors:  Victoria Cachofeiro; Marian Goicochea; Soledad García de Vinuesa; Pilar Oubiña; Vicente Lahera; José Luño
Journal:  Kidney Int Suppl       Date:  2008-12       Impact factor: 10.545

9.  Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy.

Authors:  Alexandra Scholze; Vera Jankowski; Lars Henning; Wiltrud Haass; Antje Wittstock; Sukhbaatar Suvd-Erdene; Walter Zidek; Martin Tepel; Joachim Jankowski
Journal:  Nephron Clin Pract       Date:  2007-07-05

Review 10.  Renal ammonia metabolism and transport.

Authors:  I David Weiner; Jill W Verlander
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

View more
  3 in total

1.  Photoacoustic detection of ammonia exhaled by individuals with chronic kidney disease.

Authors:  Liana Genuncio Silva; Sâmylla Cristina Espécie Bueno; Marcelo Gomes da Silva; Leonardo Mota; Marcelo Silva Sthel; Maria Priscila Pessanha de Castro; Raymundo Martins Santiago Neto; Valeska Mansur Kuba
Journal:  Lasers Med Sci       Date:  2021-05-28       Impact factor: 3.161

2.  Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease.

Authors:  Juliane Obermeier; Phillip Trefz; Josephine Happ; Jochen K Schubert; Hagen Staude; Dagmar-Christiane Fischer; Wolfram Miekisch
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

Review 3.  Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease.

Authors:  Pedro H Imenez Silva; Robert Unwin; Ewout J Hoorn; Alberto Ortiz; Francesco Trepiccione; Rikke Nielsen; Vesna Pesic; Gaye Hafez; Denis Fouque; Ziad A Massy; Chris I De Zeeuw; Giovambattista Capasso; Carsten A Wagner
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.